Physician profile
Adenike Oluwaseun Sonaike
NPI 1114423324
$4,670.92
in general payments reported to CMS, 2019-2025
20 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 89% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $2,833 · 2023: $269 · 2024: $158 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,068 · Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,067.89 |
| Food and Beverage | $656.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,381.03 | 2022-2025 | |
| Seapearl East, INC | $1,317.90 | 2022-2025 | |
| Stryker Corporation | $1,310.36 | 2022-2025 | Prostep, Citrefix, Augment Injectable |
| Paragon 28, INC. | $158.86 | 2023-2024 | Total Talus, Mini Monster |
| Organogenesis INC. | $122.35 | 2022 | |
| Smith+Nephew, INC. | $72.49 | 2021 | |
| Bioventus LLC | $68.78 | 2022 | |
| Zimmer Biomet Holdings, INC. | $33.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $31.35 | 2022-2023 | Seglentis |
| Orthofix Medical, INC. | $23.11 | 2025 | Physio-Stim |
| Orpyx Medical Technologies US INC. | $22.07 | 2023 | Orpyx Si |
| Nevro Corp. | $17.69 | 2022 | |
| Abbvie INC. | $16.07 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.35 | 2022 | |
| Averitas Pharma INC. | $14.13 | 2023 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $13.65 | 2022 | |
| Tactile Systems Technology INC | $13.55 | 2023 | Entre Plus, Flexitouch Plus |
| Medartis INC. | $13.27 | 2022 | |
| Heron Therapeutics, INC. | $12.74 | 2021 | |
| Horizon Therapeutics Plc | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adenike Sonaike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.